Clinical Validation of the LumiraDx SARS-CoV-2 & Flu A/B Combo Test

Clinical trial NCT05787444 · COMPLETED

Trial details

NCT number: NCT05787444
Sponsor: LumiraDx UK Limited
Status: COMPLETED
Study type: OBSERVATIONAL

SARS-CoV-2 Influenza A Influenza B Asymptomatic COVID-19

Start date: 2023-05-04
Primary completion: 2024-04-02
Enrollment: 1081

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.